Published in J Virol on February 01, 1990
Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer (2010) 4.99
Mechanisms of human papillomavirus-induced oncogenesis. J Virol (2004) 3.95
Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol (1993) 2.92
Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol (1998) 2.62
The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol (1992) 2.61
Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600. Proc Natl Acad Sci U S A (2005) 2.51
A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci U S A (1990) 2.46
The human papillomavirus E7 oncoprotein. Virology (2008) 2.32
Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J Virol (1992) 2.24
Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol (1996) 2.12
Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci U S A (1992) 2.10
In vitro biological activities of the E6 and E7 genes vary among human papillomaviruses of different oncogenic potential. J Virol (1991) 2.00
Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. J Virol (1993) 1.92
Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol (1993) 1.82
CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III). Histopathology (2007) 1.68
Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol (2001) 1.66
Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol (1996) 1.57
Tumorigenicity by human papillomavirus type 16 E6 and E7 in transgenic mice correlates with alterations in epithelial cell growth and differentiation. J Virol (1993) 1.54
Biochemical and biological differences between E7 oncoproteins of the high- and low-risk human papillomavirus types are determined by amino-terminal sequences. J Virol (1991) 1.50
Targeted degradation of the retinoblastoma protein by human papillomavirus E7-E6 fusion proteins. EMBO J (1992) 1.43
Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J Virol (1992) 1.41
Apoptotic caspases regulate induction of iPSCs from human fibroblasts. Cell Stem Cell (2010) 1.37
The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J Virol (1993) 1.35
Human papillomavirus type 18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J Virol (1993) 1.32
Biology of human papillomaviruses. Int J Exp Pathol (2001) 1.31
The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc Natl Acad Sci U S A (2005) 1.31
Disruption of the G1/S transition in human papillomavirus type 16 E7-expressing human cells is associated with altered regulation of cyclin E. J Virol (1998) 1.24
Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology (2012) 1.23
Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J Virol (1992) 1.20
Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol (1996) 1.18
Negative charge at the casein kinase II phosphorylation site is important for transformation but not for Rb protein binding by the E7 protein of human papillomavirus type 16. Proc Natl Acad Sci U S A (1991) 1.18
Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product. J Virol (1991) 1.14
In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction. PLoS One (2014) 1.13
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol (2008) 1.09
Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J Virol (2001) 1.08
Human papillomavirus type 33 in a tonsillar carcinoma generates its putative E7 mRNA via two E6* transcript species which are terminated at different early region poly(A) sites. J Virol (1992) 1.06
E2 proteins from high- and low-risk human papillomavirus types differ in their ability to bind p53 and induce apoptotic cell death. J Virol (2006) 1.03
Expression of the p16 and Ki-67 in relation to the grade of cervical intraepithelial neoplasia and high-risk human papillomavirus infection. J Gynecol Oncol (2008) 1.02
Recurrent respiratory papillomatosis. Otolaryngol Clin North Am (2012) 0.92
Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. Proc Natl Acad Sci U S A (1992) 0.91
Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression. J Virol (1991) 0.90
Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol (2014) 0.90
Transforming properties of the cottontail rabbit papillomavirus oncoproteins Le6 and SE6 and of the E8 protein. J Virol (1996) 0.89
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. J Virol (2001) 0.88
Mitosis-specific hyperphosphorylation of Epstein-Barr virus nuclear antigen 2 suppresses its function. J Virol (2004) 0.87
The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb. J Mol Biol (2014) 0.85
Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein. Clin Vaccine Immunol (2008) 0.85
Expression of P16 in high-risk human papillomavirus related lesions of the uterine cervix in a government hospital, Malaysia. Diagn Pathol (2014) 0.82
The binding domain structure of retinoblastoma-binding proteins. Protein Sci (1993) 0.82
Binding of p110 retinoblastoma protein inhibits nuclear import of simian virus SV40 large tumor antigen. J Biol Chem (2010) 0.80
The upstream regulatory region of human papillomavirus type 31 is insensitive to glucocorticoid induction. J Virol (2002) 0.79
Low- and high-risk human papillomavirus E7 proteins regulate p130 differently. Virology (2010) 0.79
Validation of a DNA methylation HPV triage classifier in a screening sample. Int J Cancer (2016) 0.78
Different Isoforms of HPV-16 E7 Protein are Present in Cytoplasm and Nucleus. Open Virol J (2008) 0.78
The RB tumor suppressor at the intersection of proliferation and immunity: relevance to disease immune evasion and immunotherapy. Cell Cycle (2015) 0.77
Human papillomavirus type 6 E7 protein is a substrate in vitro of protein kinase C. Biochem J (1995) 0.77
Activation of Cdc2 contributes to apoptosis in HPV E6 expressing human keratinocytes in response to therapeutic agents. J Mol Biol (2007) 0.77
The association of mammalian DREAM complex and HPV16 E7 proteins. Am J Cancer Res (2015) 0.75
Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer. BMC Cancer (2017) 0.75
Prediction of high-risk types of human papillomaviruses using statistical model of protein "sequence space". Comput Math Methods Med (2015) 0.75
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A (1983) 14.73
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
Human papillomavirus type 16 DNA sequence. Virology (1985) 9.44
Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A (1986) 7.78
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J (1986) 7.60
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli. J Virol (1984) 6.73
The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell (1988) 6.28
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
An adenovirus E1a protein region required for transformation and transcriptional repression. Cell (1986) 4.56
Molecular cloning of viral DNA from human genital warts. J Virol (1981) 4.50
Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science (1988) 4.15
Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src. Mol Cell Biol (1986) 3.99
SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell (1989) 3.88
The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature (1987) 3.85
Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci U S A (1987) 3.72
Point mutational inactivation of the retinoblastoma antioncogene. Science (1989) 3.37
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol (1989) 3.02
Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J Virol (1989) 3.01
A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol (1989) 3.00
The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol (1987) 2.90
Identification of the HPV-16 E6 protein from transformed mouse cells and human cervical carcinoma cell lines. EMBO J (1987) 2.84
Identification of early proteins of the human papilloma viruses type 16 (HPV 16) and type 18 (HPV 18) in cervical carcinoma cells. EMBO J (1987) 2.56
Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol Cell Biol (1987) 2.38
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res (1988) 1.89
The simian virus 40 large T antigen. A lot packed into a little. Mol Biol Med (1987) 1.77
A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth. J Virol (1986) 1.68
Human papillomavirus type 16 E7 protein expressed in Escherichia coli and monkey COS-1 cells: immunofluorescence detection of the nuclear E7 protein. Virology (1989) 1.37
Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol (1986) 1.32
Characterization of human papillomavirus type 6b DNA isolated from an invasive squamous carcinoma of the vulva. Virology (1988) 1.23
Expression of the human papillomavirus type 18 E7 gene by a cassette-vector system for the transcription and translation of open reading frames in eukaryotic cells. EMBO J (1987) 1.17
The noncoding region of HPV-6vc contains two distinct transcriptional enhancing elements. Virology (1986) 1.12
Identification and characterization of the CRPV E7 protein expressed in COS-7 cells. Virology (1988) 1.02
Identification of HPV 16 early genes retained in cervical carcinomas. Virology (1988) 1.00
The marriage of oncogenes and anti-oncogenes. Trends Genet (1988) 0.80
Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A (1986) 7.78
Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol (1989) 3.02
The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol (1987) 2.90
Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. Proc Natl Acad Sci U S A (1982) 2.65
Effective vaccination against papilloma development by immunization with L1 or L2 structural protein of cottontail rabbit papillomavirus. Virology (1992) 2.53
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther (2004) 2.42
Differences exist between viral transcripts in cottontail rabbit papillomavirus-induced benign and malignant tumors as well as non-virus-producing and virus-producing tumors. J Virol (1984) 2.13
Differences in the ribosomal protein of free and membrane bound polysomes of chick embryo cells. Biochem Biophys Res Commun (1970) 1.93
Two colinear and spliced viral transcripts are present in non-virus-producing benign and malignant neoplasms induced by the shope (rabbit) papilloma virus. J Virol (1982) 1.83
Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol (1997) 1.82
Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp Neurol (1998) 1.68
c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ (1993) 1.60
Physiologically induced changes in the property of phenylalanine tRNA in Escherichia coli. J Mol Biol (1968) 1.52
Human papillomavirus deoxyribonucleic acid in adenocarcinoma and adenosquamous carcinoma of the uterine cervix. Obstet Gynecol (1986) 1.40
Multiple copies of Shope virus DNA are present in cells of benign and malignant non-virus-producing neoplasms. J Virol (1979) 1.39
Temporal usage of multiple promoters during the life cycle of human papillomavirus type 31b. J Virol (1998) 1.37
Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int (1992) 1.36
Identification and preliminary characterization of protein-cysteine farnesyltransferase. Proc Natl Acad Sci U S A (1990) 1.33
Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region. Proc Natl Acad Sci U S A (1984) 1.31
Genetic analysis of CRPV pathogenesis: the L1 open reading frame is dispensable for cellular transformation but is required for papilloma formation. Virology (1989) 1.31
The primary target cells of the high-risk cottontail rabbit papillomavirus colocalize with hair follicle stem cells. J Virol (1996) 1.29
Human papillomavirus type 31b E1 and E2 transcript expression correlates with vegetative viral genome amplification. Virology (1998) 1.28
Identification of the major cottontail rabbit papillomavirus late RNA cap site and mapping and quantitation of an E2 and minor E6 coding mRNA in papillomas and carcinomas. Virology (1987) 1.24
Progression from papilloma to carcinoma is accompanied by changes in antibody response to papillomavirus proteins. J Virol (1993) 1.24
Cottontail rabbit papillomavirus L1 protein-based vaccines: protection is achieved only with a full-length, nondenatured product. J Virol (1993) 1.23
Radioimmunoassay of somatostatin. Metabolism (1978) 1.22
Replication and assembly of human papillomaviruses. J Dent Res (2009) 1.20
Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J Virol (1992) 1.20
Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits. J Virol (1994) 1.17
Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology (1997) 1.16
3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res (1997) 1.15
Shope papilloma virus DNA is extensively methylated in non-virus-producing neoplasms. Virology (1983) 1.14
E2 of cottontail rabbit papillomavirus is a nuclear phosphoprotein translated from an mRNA encoding multiple open reading frames. J Virol (1988) 1.12
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr (1990) 1.11
Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA. J Virol (1997) 1.11
Transforming growth factor beta1 induces differentiation in human papillomavirus-positive keratinocytes. J Virol (1996) 1.08
Regression of papillomas induced by cottontail rabbit papillomavirus is associated with infiltration of CD8+ cells and persistence of viral DNA after regression. J Virol (1997) 1.03
Transcription of the viral genome in papillomas and carcinomas induced by the Shope virus. Virology (1981) 1.02
Identification and characterization of the CRPV E7 protein expressed in COS-7 cells. Virology (1988) 1.02
Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas. J Virol (1995) 1.01
Human papillomavirus type 16 immortalized cervical keratinocytes contain transcripts encoding E6, E7, and E2 initiated at the P97 promoter and express high levels of E7. Virology (1991) 1.01
Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7. J Rheumatol (2001) 0.99
Neuroprotective and memory-related actions of novel alpha-7 nicotinic agents with different mixed agonist/antagonist properties. J Pharmacol Exp Ther (1998) 0.98
Differential in vivo aminoacylation and utilization of homologous species of E. coli transfer RNA. Cold Spring Harb Symp Quant Biol (1966) 0.98
Two novel promoters in the upstream regulatory region of human papillomavirus type 31b are negatively regulated by epithelial differentiation. J Virol (1999) 0.97
Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release. Biochem Biophys Res Commun (1977) 0.96
Temporal and spatial expression of the E5a protein during the differentiation-dependent life cycle of human papillomavirus type 31b. Virology (1998) 0.96
An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs. Acta Endocrinol (Copenh) (1977) 0.94
The E7 protein of human papillomavirus 8 is a nonphosphorylated protein of 17 kDa and can be generated by two different mechanisms. Virology (1990) 0.94
Two separable cytoplasmic pools of native ribosomal subunits in chick embryo tissue culture cells. Biochim Biophys Acta (1972) 0.94
Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma. Mol Cell Biol (2000) 0.93
Cottontail rabbit papillomavirus-specific transcripts in transplantable tumors with integrated DNA. Virology (1984) 0.92
The two proteins encoded by the cottontail rabbit papillomavirus E6 open reading frame differ with respect to localization and phosphorylation. J Virol (1988) 0.90
Transcription of the cottontail rabbit papillomavirus early region and identification of two E6 polypeptides in COS-7 cells. J Virol (1987) 0.90
Transforming properties of the cottontail rabbit papillomavirus oncoproteins Le6 and SE6 and of the E8 protein. J Virol (1996) 0.89
Binding of the human papillomavirus type 16 p97 promoter by the adeno-associated virus Rep78 major regulatory protein correlates with inhibition. J Biol Chem (1999) 0.89
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity. Am J Clin Oncol (1997) 0.88
Tryptic peptide mapping of picomolar quantities of protein labeled with the Bolton--Hunter reagent. Anal Biochem (1981) 0.88
The late region differentially regulates the in vitro transformation by cottontail rabbit papillomavirus DNA in different cell types. Virology (1991) 0.88
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme. Br J Cancer (2009) 0.87
A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1999) 0.87
Induction of productive human papillomavirus type 11 life cycle in epithelial cells grown in organotypic raft cultures. Virology (2006) 0.87
Fetal cells in the maternal circulation: isolation by multiparameter flow cytometry and confirmation by polymerase chain reaction. Hum Reprod (1991) 0.87
Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity. Immunol Rev (1997) 0.86
Intended goals and appropriate treatment: an alternative to the ordinary/extraordinary distinction. J Med Ethics (1984) 0.86
Brain function, learning styles, and cancer patient education. Semin Oncol Nurs (1991) 0.86
Diverticulum of the hepatic duct: a rare anomaly. Radiology (1976) 0.85
Tumor regression is associated with a specific immune response to the E2 protein of cottontail rabbit papillomavirus. Virology (1995) 0.85
The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice. Neuroscience (2007) 0.85
Issues in assessing and interpreting quality of life in patients with malignant glioma. Semin Oncol (2000) 0.83
Enzymes as reagents in peptide synthesis: enzymatic removal of amine protecting groups. Proc Natl Acad Sci U S A (1975) 0.83
Correlation of TGF beta 1 overexpression with down-regulation of proliferation-inducing molecules in HPV-11 transformed human tissue xenografts. Anticancer Res (2000) 0.82
A variant of CRPV DNA preferentially maintained as a plasmid in NIH 3T3 cells and characterization of its transcripts in nude mouse tumors. Virology (1987) 0.82
Structure-activity relationships of eighteen somatostatin analogues on gastric secretion. J Physiol (1978) 0.82
Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proc Natl Acad Sci U S A (1993) 0.82
Tetrasomy is induced by human papillomavirus type 18 E7 gene expression in keratinocyte raft cultures. Cancer Res (2001) 0.81
T-cell response to cottontail rabbit papillomavirus structural proteins in infected rabbits. J Virol (1994) 0.81
Inhibition/stimulation of bovine papillomavirus by adeno-associated virus is time as well as multiplicity dependent. Virology (1998) 0.80
Effect of the HIV nucleoside reverse transcriptase inhibitor zidovudine on the growth and differentiation of primary gingival epithelium. HIV Med (2012) 0.80
Immunoglobulin M synthesized by human lymphoblastoid cells: interaction with Staphylococcus aureus and protein A. J Immunol (1978) 0.79
A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders. Leuk Lymphoma (2000) 0.79
The HIV protease inhibitor lopinavir/ritonavir (Kaletra) alters the growth, differentiation and proliferation of primary gingival epithelium. HIV Med (2010) 0.79
Neuroprotective effects of 2,4-dimethoxybenzylidene anabaseine (DMXB) and tetrahydroaminoacridine (THA) in neocortices of nucleus basalis lesioned rats. Brain Res (1998) 0.78
Hydrolysis of methylprednisolone acetate by human serum cholinesterase. Drug Metab Dispos (1982) 0.78
Characterization of polysome-associated RNA from influenza virus-infected cells. J Virol (1976) 0.78
Distribution of polysomes in mouse brain tissue. J Neurochem (1971) 0.77
Differences in the subunit exchange between native and runoff single ribosomes. Biochim Biophys Acta (1974) 0.77
Some reaction of N-hydroxysuccinimide esters of o-nitrophenylsulphenyl-protected glutamine and asparagine. Chem Ind (1969) 0.77
[Rediscovery of a neuroleptic drug in a new form: clopenthixol]. Schweiz Rundsch Med Prax (1972) 0.76
Transforming growth factor beta 1 (TGF beta 1) down-regulates expression and function of proliferation-inducing molecules in HPV-transformed cells. Anticancer Res (2000) 0.76
A phase I trial of intermittent high-dose alpha-interferon and dexamethasone in metastatic renal cell carcinoma. Ann Oncol (1995) 0.76
HIV nucleoside reverse transcriptase inhibitors efavirenz and tenofovir change the growth and differentiation of primary gingival epithelium. HIV Med (2013) 0.75
[The role of the healer in neuropsychiatric care in the Revolutionary People's Republic of Guinea]. Acta Psychiatr Belg (1983) 0.75
[Cerebral atrophy, diagnosed by tomodensitometry, versus Rorschach organic psychosyndrome in a psychiatric population]. Acta Psychiatr Belg (1983) 0.75
Thin-layer chromatographic classification of antibiotics exhibiting antitumor properties. J Chromatogr (1977) 0.75
[Cerebral atrophy, diagnosis using tomodensitometry compared with the new Wechsler intelligence scale in a psychiatric population]. Acta Psychiatr Belg (1984) 0.75
[Télé-accueil: advantages and inadequacies of the tool. Viewpoint of the neuropsychiatrist]. Acta Psychiatr Belg (1984) 0.75
A study of pituitary thyrotropin, its subunits, and messenger ribonucleic acids in nonthyroidal illness. Metabolism (1988) 0.75